Osteosarcoma
Zapobieganie i profilaktyka

Osteosarcoma jest najczęstszym pierwotnym złośliwym nowotworem kości, charakteryzującym się agresywnym wzrostem i tendencją do przerzutów, głównie do płuc. Dotyka głównie dzieci, młodzież oraz psy dużych ras w średnim i starszym wieku. Nie istnieją potwierdzone metody zapobiegania osteosarcomie, jednak ograniczenie ekspozycji na promieniowanie jonizujące, herbicydy, pestycydy oraz unikanie palenia tytoniu może potencjalnie zmniejszyć ryzyko. Radioterapia profilaktyczna przeciwko kostniejącemu zapaleniu heterotopowemu (HO) po zabiegach ortopedycznych, stosowana w dawce 7 Gy w pojedynczej frakcji, choć skuteczna, niesie ryzyko indukcji osteosarcomy. Alternatywnie, NLPZ mogą być stosowane w profilaktyce HO, jednak ich stosowanie jest ograniczone przez działania niepożądane ze strony przewodu pokarmowego. Wczesne wykrycie i regularne badania kontrolne, zwłaszcza u osób z genetycznym obciążeniem (np. zespół Li-Fraumeni, dziedziczny retinoblastoma), są kluczowe dla poprawy rokowania.

Osteosarcoma – definicja i podstawowe informacje

Osteosarcoma (kostniakomięsak) to najczęściej występujący pierwotny nowotwór złośliwy kości, dotykający zarówno ludzi, jak i zwierzęta. Choroba ta charakteryzuje się powstawaniem nieprawidłowych komórek kostnych, które mogą niszczyć okoliczne tkanki oraz mają znaczną tendencję do tworzenia przerzutów, głównie do płuc.1 Jest to nowotwór szczególnie istotny u dzieci i młodzieży w wieku rozwojowym oraz u psów średnich i dużych ras w średnim i starszym wieku.2

Możliwości zapobiegania osteosarcoma

Obecnie nie istnieją potwierdzone naukowo, skuteczne metody zapobiegania osteosarcomie u ludzi.34 W przeciwieństwie do wielu nowotworów wieku dorosłego, których ryzyko można zmniejszyć poprzez określone zmiany stylu życia (takie jak utrzymywanie prawidłowej masy ciała czy zaprzestanie palenia), nie zidentyfikowano dotychczas specyficznych czynników środowiskowych lub związanych ze stylem życia, które jednoznacznie wpływałyby na rozwój osteosarcoma.56

Podobna sytuacja występuje w przypadku osteosarcoma u psów, gdzie również nie ma potwierdzonej metody zapobiegania temu nowotworowi.78

Ograniczanie znanych czynników ryzyka

Pomimo braku jednoznacznych metod prewencji, zidentyfikowano pewne czynniki ryzyka, których ograniczenie może potencjalnie zmniejszyć prawdopodobieństwo rozwoju osteosarcoma:

  • Unikanie niepotrzebnej ekspozycji na promieniowanie jonizujące, które jest znanym czynnikiem zwiększającym ryzyko rozwoju osteosarcoma910
  • Ograniczenie ekspozycji na pewne substancje chemiczne, takie jak herbicydy i pestycydy, które mogą zwiększać ryzyko nowotworu11
  • Unikanie palenia tytoniu, które zmniejsza gęstość kości i osłabia ich strukturę12

Profilaktyczna radioterapia a ryzyko osteosarcoma

Należy zwrócić szczególną uwagę na fakt, że radioterapia stosowana profilaktycznie w zapobieganiu kostniejącemu zapaleniu heterotopowemu (HO) po zabiegach ortopedycznych, może być czynnikiem ryzyka rozwoju osteosarcoma. Chociaż jest to rzadkie powikłanie, pacjenci powinni być informowani o potencjalnym ryzyku wystąpienia nowotworu indukowanego promieniowaniem po profilaktyce HO.13

Skuteczność pojedynczej frakcji radioterapii dawką 7Gy została określona jako równoważna z wyższymi dawkami lub wieloma frakcjami w zapobieganiu HO. Jednak poza ryzykiem rozwoju mięsaka indukowanego promieniowaniem, ta metoda wiąże się z dodatkowymi wadami, w tym znacznymi kosztami i trudnościami w planowaniu leczenia ze względu na wąskie 3-4 dniowe okno terapeutyczne po zabiegu operacyjnym.14

Niesteroidowe leki przeciwzapalne (NLPZ) mogą służyć jako alternatywna metoda profilaktyki HO, prawdopodobnie poprzez ogólnoustrojowe hamowanie prostaglandyn, które promują rozwój komórek osteoprogenitorowych. W porównaniu z radioterapią, NLPZ są znacznie tańszą opcją, ale pacjenci często mają słabą przestrzeganie zaleceń z powodu zapalenia żołądka lub innych powikłań żołądkowo-jelitowych.15

Profilaktyka zdrowotna i wczesne wykrywanie

Chociaż nie możemy zapobiec osteosarcomie, wczesne wykrycie i interwencja mogą znacząco wpłynąć na rokowanie:16

  • Regularne badania kontrolne są kluczowe, szczególnie dla osób z czynnikami ryzyka17
  • Świadomość potencjalnych objawów i szybka konsultacja lekarska w przypadku ich wystąpienia18
  • Poradnictwo genetyczne dla osób z rodzinnym obciążeniem zespołami genetycznymi zwiększającymi ryzyko osteosarcoma, takimi jak zespół Li-Fraumeni czy dziedziczny retinoblastoma19

Prozdrowotny styl życia

Chociaż nie istnieją jednoznaczne dowody, że zdrowy styl życia zapobiega osteosarcomie, ogólne zalecenia prozdrowotne mogą mieć pozytywny wpływ na ogólny stan zdrowia i potencjalnie zmniejszać ryzyko chorób nowotworowych:20

  • Utrzymanie aktywności fizycznej poprzez regularne ćwiczenia21
  • Stosowanie zrównoważonej diety bogatej w owoce, warzywa, pełnoziarniste produkty zbożowe, ryby i produkty mleczne o niskiej zawartości tłuszczu22
  • Unikanie przetworzonej żywności o wysokiej zawartości tłuszczów nasyconych23
  • Ograniczenie lub unikanie spożycia alkoholu (maksymalnie 2 drinki dziennie dla mężczyzn i 1 drink dla kobiet)24
  • Zaprzestanie palenia tytoniu25
  • Utrzymywanie prawidłowej masy ciała26
  • Zapewnienie odpowiedniej podaży witaminy D dla zdrowia kości27

Zapobieganie nawrotom i przerzutom osteosarcoma

Choć nie ma sprawdzonych metod zapobiegania samemu osteosarcomie, istnieją obiecujące kierunki badań dotyczące zapobiegania nawrotom i przerzutom tego nowotworu.

Zapobieganie nawrotom po resekcji przerzutów płucnych

Badania kliniczne fazy 2b dla OST-HER2 wykazały statystycznie istotne wyniki w zapobieganiu nawrotom osteosarcoma z całkowicie resekcjonowanymi przerzutami do płuc. OST-HER2 to innowacyjna immunoterapia wykorzystująca biomodyfikowaną formę bakterii Listeria monocytogenes do wywołania silnej odpowiedzi immunologicznej przeciwko komórkom nowotworowym wykazującym ekspresję HER2.28

Ta immunoterapia typu „off-the-shelf” ma na celu zapobieganie przerzutom, opóźnianie nawrotów, niszczenie guzów pierwotnych wykazujących ekspresję HER2 oraz potencjalnie zwiększenie ogólnej przeżywalności. FDA przyznała OST-HER2 status leku sierocego w leczeniu osteosarcoma w 2021 roku.29

Zapobieganie przerzutom przyspieszonymi przez zabieg chirurgiczny

Badania na modelach zwierzęcych wykazały, że przerzuty przyspieszone przez zabieg chirurgiczny są częściowo mediowane przez zmiany w fenotypie makrofagów wspierające rozwój guza. Celowane terapie farmakologiczne, które zapobiegają zmianom fenotypu makrofagów w kierunku wspierającym guzy, mogą być stosowane okołooperacyjnie w celu złagodzenia przyspieszonych przez zabieg chirurgiczny przerzutów i poprawy korzyści terapeutycznych zabiegu.30

Gefitynib, lek już zatwierdzony przez FDA, został zidentyfikowany jako potencjalny dodatek chirurgiczny do łagodzenia niepożądanych konsekwencji operacji. Leczenie gefitynibem zapobiegło zmianom fenotypu makrofagów wspierających guzy i doprowadziło do zmniejszenia przerzutów.31 Okołooperacyjne leczenie gefitynibem spowodowało odwrócenie fenotypu makrofagów wspierającego guzy do bardziej przeciwnowotworowego stanu, co wiązało się ze znacznym zmniejszeniem przerzutów po operacji.32

Zapobieganie wielolekooporności w osteosarcoma

Głównym ograniczeniem skuteczności chemioterapii w osteosarcomie jest rozwój wielolekooporności (MDR). Zapobieganie powstawaniu MDR podczas leczenia chemioterapią było wysokim priorytetem w onkologii klinicznej i badawczej, ale pozostaje trudnym do osiągnięcia celem.33

NSC23925, małocząsteczkowy związek zidentyfikowany jako skuteczny i selektywny inhibitor glikoproteiny P (Pgp), wykazuje zdolność do zapobiegania rozwojowi MDR w komórkach osteosarcoma U-2OS i Saos. Badania sugerują, że NSC23925 może zapobiegać rozwojowi MDR poprzez specyficzne zapobieganie nadekspresji Pgp.34

Zapobieganie nadekspresji Pgp zostało zidentyfikowane jako skuteczne podejście do hamowania rozwoju MDR podczas leczenia lekami chemioterapeutycznymi. NSC23925 zapobiega zwiększonej ekspresji Pgp, a tym samym zapobiega zwiększonemu wypływowi i/lub zmniejszonemu napływowi leków podczas leczenia chemioterapeutycznego.35

Nanokompleksy domieszkowane europem

Prowadzone są również badania nad nanokompleksami hybrydowymi domieszkowanymi europem (Eu:SPIO@BSA) jako potencjalną strategią zapobiegania przerzutom w osteosarcomie. Wyniki badań sugerują, że nanokompleks Eu:SPIO@BSA, dzięki precyzyjnemu dostarczaniu, wyższej hemokompatybilności i niskiej toksyczności wątrobowej, jest potencjalnym kandydatem do poprawy skuteczności terapeutycznej w zapobieganiu przerzutom w osteosarcomie.36

Profilaktyka w trakcie leczenia osteosarcoma

Podczas leczenia osteosarcoma stosowane są różne środki profilaktyczne mające na celu zapobieganie powikłaniom związanym z terapią:37

Badania nad zapobieganiem osteosarcoma u psów

Osteosarcoma jest również najczęstszą formą nowotworu kości u psów, szczególnie dotykającą duże rasy w średnim i starszym wieku. Prowadzone są badania nad strategiami zapobiegania i leczenia tego nowotworu u psów, co może również przynieść korzyści w leczeniu osteosarcoma u ludzi.38

Jednym z kierunków badań jest zrozumienie, dlaczego psy i dzieci z komórkami immunologicznymi wewnątrz guzów kostnych przeżywają dłużej niż te, których komórki odpornościowe pozostają poza guzami. Zrozumienie krajobrazu immunologicznego, który prowadzi do poprawy odpowiedzi klinicznej, jest celowym krokiem w kierunku jaśniejszej przyszłości dla psów zmagających się z tą chorobą.39

Prowadzone są również badania mające na celu opracowanie testów umożliwiających wykrycie osteosarcoma w jego początkowej fazie lub blisko jego pochodzenia. Wczesne wykrycie z kolei umożliwi wdrożenie strategicznej profilaktyki u psów z grupy wysokiego ryzyka.40

Istnieją również niektóre wstępne dowody na to, że opóźnienie kastracji lub sterylizacji u ras wysokiego ryzyka do co najmniej jednego roku życia i umożliwienie samicom przejścia przynajmniej jednego cyklu płciowego może zmniejszyć ryzyko osteosarcoma, chociaż nie jest to gwarantowana strategia profilaktyczna.41

Podsumowanie obecnego stanu wiedzy

Obecnie nie istnieją potwierdzone naukowo metody zapobiegania osteosarcomie. Większość znanych czynników ryzyka dla osteosarcoma nie może być modyfikowana. Poza ekspozycją na promieniowanie (zwykle podczas radioterapii), nie są znane czynniki związane ze stylem życia lub środowiskowe powodujące osteosarcomę.42

Chociaż specyficzne metody zapobiegania osteosarcomie mogą być ograniczone, proaktywne środki, takie jak zrozumienie czynników ryzyka i szukanie pomocy medycznej w odpowiednim czasie, mogą znacząco wpłynąć na wyniki leczenia. Kompleksowe podejście obejmujące redukcję ryzyka i wczesne wykrywanie jest kluczowe dla zarządzania osteosarcomą.43

Interakcja między badaniami nad rakiem i opieką nad zwierzętami a badaniami nad rakiem i opieką nad ludźmi jest kluczowa dla odkrywania nowej wiedzy i strategii leczenia tego nowotworu.44

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Learn About Osteosarcoma (Bone Cancer) in Dogs | PetCure Oncology
    https://petcureoncology.com/what-you-should-know-about-osteosarcoma-bone-cancer-in-dogs/
    Osteosarcoma, or bone cancer, is the most common bone cancer seen in dogs. […] Although there is no sure way to prevent this type of cancer from occurring in dogs, regular check-ups with your veterinarian are highly recommended in order to catch any potential signs or symptoms early on. […] Once diagnosed, it is recommended to seek treatment as soon as possible in order to slow down the spread of the disease and reduce pain for your dog. […] Sometimes palliative treatment is recommended. Palliative treatment aims to make your pet more comfortable but doesn’t provide a cure, and can include conventional radiation therapy and drugs to reduce pain. […] Early detection is critical for ensuring successful treatment outcomes.
  • #2 Tackling new strategies for canine bone cancer at MCC | Masonic Cancer Center
    https://cancer.umn.edu/news/tackling-new-strategies-canine-bone-cancer-mcc
    Osteosarcoma, the most common form of bone cancer in dogs, is a tumor that usually affects the limbs of middle-aged to older, large breed dogs and carries a dire prognosis. […] Our projects are addressing the impact of this disease by developing strategies for prevention with the intent of reducing overall incidence and by improving our understanding of how we can use the immune system to improve treatment outcomes. […] The interplay between cancer research and care for animals and cancer research and care for humans is critical to uncovering new knowledge and strategies for writing cancer’s last chapter.
  • #3 Osteosarcoma Causes, Risk Factors, and Prevention | American Cancer Society
    https://www.cancer.org/cancer/types/osteosarcoma/causes-risks-prevention.html
    The risk of many adult cancers can be reduced with certain lifestyle changes (such as staying at a healthy weight or quitting smoking), but at this time there are no known ways to prevent osteosarcoma. […] Most known risk factors for osteosarcoma cannot be changed. Other than radiation therapy, there are no known lifestyle-related or environmental causes of osteosarcoma, so at this time there is no known way to protect against or prevent most of these cancers.
  • #4 Can Osteosarcoma Be Prevented? | American Cancer Society
    https://www.cancer.org/cancer/types/osteosarcoma/causes-risks-prevention/prevention.html
    The risk of many adult cancers can be reduced with certain lifestyle changes (such as staying at a healthy weight or quitting smoking), but at this time there are no known ways to prevent osteosarcoma. […] Other than exposure to radiation (usually during radiation therapy), there are no known lifestyle-related or environmental causes of osteosarcoma, so at this time there is no known way to protect against or prevent most of these cancers.
  • #5
    https://www.americanoncology.com/cancer-we-treat/prevention/osteosarcoma
    There are currently no methods to prevent osteosarcoma, as no lifestyle factor is known that increases the risk of osteosarcoma. […] However, quitting smoking, exercising, eating a healthy diet, and improving your lifestyle, can prevent several cancers.
  • #6 Bone cancer | Causes, Symptoms & Treatments | Cancer Council
    https://www.cancer.org.au/cancer-information/types-of-cancer/bone-cancer
    There are no proven measures to prevent bone cancer.
  • #7 Osteosarcoma in dogs | Joii Pet Care
    https://www.joiipetcare.com/health-conditions/dog/osteosarcoma/
    Osteosarcoma in dogs can be prevented? Sadly there is no known prevention for osteosarcoma.
  • #8 Osteosarcoma in Dogs
    https://www.embracepetinsurance.com/health/osteosarcoma
    As with most cancers of genetic and indeterminate origin, there is no accepted approach to the prevention of osteosarcoma.
  • #9 Osteosarcoma | Endocrine Society
    https://www.endocrine.org/patient-engagement/endocrine-library/osteosarcoma
    There is nothing that can be done to prevent osteosarcoma. Minimizing exposure to radiation might be a strategy to decrease the chances of osteosarcoma appearing. […] Some risk factors include rapid bone growth with an increased risk during a child’s growth spurts. Genetic factors linked to osteosarcoma by a mutation of the retinoblastoma gene or TP53 gene. In adults, Paget’s disease (increased activity of the osteoclasts, the cells that chew bone during normal bone remodeling) and exposure to radiation increase the chances of osteosarcoma.
  • #10 Best Osteosarcoma Cancer Treatment in Delhi, India | Symptoms, Causes, and Treatment Therapy
    https://www.maxhealthcare.in/our-specialities/cancer-care-oncology/conditions-treatments/osteosarcoma
    Osteosarcoma prevention primarily focuses on reducing known risk factors and promoting healthy lifestyle habits. While osteosarcoma is not entirely preventable, some measures may help lower the risk: […] Avoid Radiation Exposure: Minimise exposure to ionising radiation, as it is a known risk factor for osteosarcoma development. This includes limiting unnecessary medical imaging procedures involving radiation. […] Limit Chemical Exposure: Limit exposure to chemicals known to increase the risk of osteosarcoma, such as certain herbicides and pesticides. Protective measures should be taken when handling potentially carcinogenic substances. […] Healthy Lifestyle Choices: Encourage maintaining a healthy lifestyle, including a balanced diet rich in fruits and vegetables, regular physical activity, and avoidance of tobacco and excessive alcohol consumption.
  • #11 Best Osteosarcoma Cancer Treatment in Delhi, India | Symptoms, Causes, and Treatment Therapy
    https://www.maxhealthcare.in/our-specialities/cancer-care-oncology/conditions-treatments/osteosarcoma
    Osteosarcoma prevention primarily focuses on reducing known risk factors and promoting healthy lifestyle habits. While osteosarcoma is not entirely preventable, some measures may help lower the risk: […] Avoid Radiation Exposure: Minimise exposure to ionising radiation, as it is a known risk factor for osteosarcoma development. This includes limiting unnecessary medical imaging procedures involving radiation. […] Limit Chemical Exposure: Limit exposure to chemicals known to increase the risk of osteosarcoma, such as certain herbicides and pesticides. Protective measures should be taken when handling potentially carcinogenic substances. […] Healthy Lifestyle Choices: Encourage maintaining a healthy lifestyle, including a balanced diet rich in fruits and vegetables, regular physical activity, and avoidance of tobacco and excessive alcohol consumption.
  • #12 How to Prevent Bone Cancer? | Tips to Reduce Risk
    https://amerixcancer.com/how-to-prevent-bone-cancer/
    Bone cancer is easier to treat when it is diagnosed at an early stage. By understanding the risk factors and preventative measures for bone cancer, you can reduce the chance of getting bone cancer. […] Preventing bone cancer can be a daunting task if you have some inherited genetic mutations or other disease conditions. Other risk factors, which are mostly lifestyle-related, can be changed. Reducing the risk factors can directly reduce your risk of getting bone cancer. […] The following measures have been found useful in several studies which focused on reducing the risk of bone cancer: […] The best way to prevent advanced-stage cancer is a routine check-up. […] Radiation is a significant risk factor for bone cancer. Completely avoid unnecessary radiation exposure. […] A high-fibre and low-fat diet with all essential nutrients and proteins should be followed. […] Physical inactivity is a significant risk of bone cancer. […] Smoking or chewing tobacco reduces bone density and weakens them. […] If you have been diagnosed with Pagets disease or osteoporosis, pay extra attention to your bone health.
  • #13 Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification | Radiation Oncology | Full Text
    https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-7-140
    Radiotherapy for prophylaxis of heterotopic ossification (HO) is commonly used in high risk patients following orthopedic surgery. […] While a rare complication, we stress the importance of informing regarding the risk of a radiation induced malignancy following HO prophylaxis. […] The idea that RT could be used to prevent HO is based largely on the assumption that osteoprogenitor cells present in soft tissues in the beginning phases of HO, would be highly mitotic and therefore sensitive to RT. […] Coventrey et al. concluded that RT was an effective means of HO prevention. […] The potential downsides to RT however, include effects on fertility, and the possibility of radiation induced malignancy. […] To maintain efficacy, treatment is generally given within 4 days of surgical intervention based on studies by Sylvester et al.
  • #14 Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification | Radiation Oncology | Full Text
    https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-7-140
    The effectiveness of a single fraction to 7Gy has been determined equivalent to higher doses or multiple fractions. […] A single fraction of 7Gy has therefore become common practice. […] Although RIS remains a rare treatment complication, there are several other disadvantages of RT in this setting including considerable costs, and scheduling difficulties given the narrow 34 day treatment window. […] Non-steroidal anti-inflammatory drugs (NSAIDs) can serve as an alternative method of HO prophylaxis presumably through systemic inhibition of prostaglandins that promote osteoprogenitor development. […] Compared to RT, NSAIDs are a considerably less expensive option, but patients often have poor compliance due to gastritis or other GI complications. […] Radiotherapy remains an effective method of prophylaxis for HO in high risk patients. […] It is important to inform patients regarding the risk of a radiation induced malignancy. […] Based on the reported case, we suggest that prior to recommending prophylactic RT for young patients at risk for HO, the potential risks should be weighed strongly against the benefits.
  • #15 Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification | Radiation Oncology | Full Text
    https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-7-140
    The effectiveness of a single fraction to 7Gy has been determined equivalent to higher doses or multiple fractions. […] A single fraction of 7Gy has therefore become common practice. […] Although RIS remains a rare treatment complication, there are several other disadvantages of RT in this setting including considerable costs, and scheduling difficulties given the narrow 34 day treatment window. […] Non-steroidal anti-inflammatory drugs (NSAIDs) can serve as an alternative method of HO prophylaxis presumably through systemic inhibition of prostaglandins that promote osteoprogenitor development. […] Compared to RT, NSAIDs are a considerably less expensive option, but patients often have poor compliance due to gastritis or other GI complications. […] Radiotherapy remains an effective method of prophylaxis for HO in high risk patients. […] It is important to inform patients regarding the risk of a radiation induced malignancy. […] Based on the reported case, we suggest that prior to recommending prophylactic RT for young patients at risk for HO, the potential risks should be weighed strongly against the benefits.
  • #16 How to Prevent Bone Cancer & Risk Factor | HCG Oncology
    http://www.hcgoncology.com/types-of-cancers/bone-cancer-prevention/
    Unfortunately, there is no confirmed answer to the question 'how to prevent bone cancer.’ However, early detection and an understanding of the bone cancer risk factors can surely increase the chances of a successful treatment. […] Though there is no definite way to prevent bone cancer, there are some things that can help in the process. […] Avoid smoking […] Healthy diet […] Limit alcohol […] Exercise […] Get checked regularly […] Understanding bone cancer prevention and risk factors is highly helpful for doctors in selecting a relevant line of treatment as per an individual patient’s needs and requirements. Also, individuals can take proactive steps to reduce their chances of developing cancer. […] Yes, early detection and timely treatment of bone diseases may help reduce the risk of bone cancer.
  • #17 Osteosarcoma Risk Factors and Prevention Measures | HCG
    https://www.hcgoncology.com/types-of-cancers/osteosarcoma-prevention/
    Osteosarcoma prevention primarily involves understanding and addressing risk factors. While it may not be entirely preventable, avoiding therapeutic radiation when possible, managing pre-existing bone conditions, and staying vigilant for hereditary factors can contribute to osteosarcoma prevention. Regular medical check-ups and awareness of potential symptoms enhance early detection and intervention. […] While specific osteosarcoma prevention methods may be limited, proactive measures such as understanding risk factors and seeking timely medical attention can significantly impact outcomes. A comprehensive approach involving risk reduction and early detection is crucial for managing osteosarcoma.
  • #18 Bone Cancer: Symptoms, Treatment & Outlook
    https://my.clevelandclinic.org/health/diseases/17745-bone-cancer
    As experts dont really know what causes bone cancers, theres currently no known way to prevent it. […] Still, you can see a healthcare provider if youre noticing unusual changes in your bones, like a lump or increasing bone pain. These symptoms dont usually mean cancer. But only a provider can diagnose whats causing the issue.
  • #19 Best Osteosarcoma Cancer Treatment in Delhi, India | Symptoms, Causes, and Treatment Therapy
    https://www.maxhealthcare.in/our-specialities/cancer-care-oncology/conditions-treatments/osteosarcoma
    Genetic Counselling: Individuals with certain genetic conditions, such as Li-Fraumeni syndrome or hereditary retinoblastoma, have an increased risk of developing osteosarcoma. Genetic counselling and testing may be recommended for individuals with a family history of these conditions. […] While these preventive measures can reduce the risk of osteosarcoma, it’s essential to remember that not all cases can be prevented. Regular medical check-ups and prompt evaluation of any concerning symptoms are crucial for early detection and treatment if osteosarcoma does occur.
  • #20 Bone Cancer Symptoms and How to Prevent It – EMC Healthcare – SAME
    https://www.emc.id/en/care-plus/bone-cancer-full-review-of-symptoms-and-early-prevention
    Unfortunately, there are no concrete steps that can be taken to prevent bone cancer because this disease is related to certain bone abnormalities, age, and genetic or hereditary factors. […] Nevertheless, having regular health check-ups can help in early detection of this disease, allowing prompt treatment. The sooner bone cancer is detected, the greater the chance of cure. Regular check-ups are also important for people at high risk of bone cancer or other types of cancer. […] Although there are no definitive preventive measures, a healthy lifestyle can help lower the risk: Stay active by exercising regularly and avoiding smoking and excessive alcohol consumption. Adopt a healthy diet by increasing consumption of fruit, vegetables, whole grains, fish and low-fat dairy products, and avoiding processed foods high in saturated fat. Maintain an ideal body weight through a combination of a healthy diet and physical activity, because obesity can increase the risk of cancer. If exposed to radiation in work or daily activities, be sure to use appropriate protection. Be aware of personal risk factors such as a family history of cancer or certain genetic conditions, and take appropriate preventative steps. Ensure adequate vitamin D intake for bone health. Avoid contact with dangerous chemicals or heavy metals that can increase the risk of bone cancer. Avoid activities that have a risk of causing bone injury. If injury occurs, seek appropriate medical treatment immediately.
  • #21 How to Prevent Bone Cancer? | Tips to Reduce Risk
    https://amerixcancer.com/how-to-prevent-bone-cancer/
    Bone cancer is easier to treat when it is diagnosed at an early stage. By understanding the risk factors and preventative measures for bone cancer, you can reduce the chance of getting bone cancer. […] Preventing bone cancer can be a daunting task if you have some inherited genetic mutations or other disease conditions. Other risk factors, which are mostly lifestyle-related, can be changed. Reducing the risk factors can directly reduce your risk of getting bone cancer. […] The following measures have been found useful in several studies which focused on reducing the risk of bone cancer: […] The best way to prevent advanced-stage cancer is a routine check-up. […] Radiation is a significant risk factor for bone cancer. Completely avoid unnecessary radiation exposure. […] A high-fibre and low-fat diet with all essential nutrients and proteins should be followed. […] Physical inactivity is a significant risk of bone cancer. […] Smoking or chewing tobacco reduces bone density and weakens them. […] If you have been diagnosed with Pagets disease or osteoporosis, pay extra attention to your bone health.
  • #22 Osteosarcoma – What You Need to Know
    https://www.drugs.com/cg/osteosarcoma.html
    Do not smoke. Smoking increases your risk for new or returning cancer. Smoking can also delay healing after treatment. Ask your healthcare provider for information if you currently smoke and need help quitting. […] Limit or do not drink alcohol as directed. Limit alcohol to 2 drinks per day if you are a man. Limit alcohol to 1 drink per day if you are a woman. A drink of alcohol is 12 ounces of beer, 5 ounces of wine, or 1½ ounces of liquor. […] Eat a variety of healthy foods. Healthy foods include fruits, vegetables, whole-grain breads, low-fat dairy products, beans, lean meats, and fish. Ask if you need to be on a special diet. […] Drink liquids as directed. You may need to drink more liquid during cancer treatment. Ask your healthcare provider how much liquid to drink each day and which liquids are best for you.
  • #23 Bone Cancer Symptoms and How to Prevent It – EMC Healthcare – SAME
    https://www.emc.id/en/care-plus/bone-cancer-full-review-of-symptoms-and-early-prevention
    Unfortunately, there are no concrete steps that can be taken to prevent bone cancer because this disease is related to certain bone abnormalities, age, and genetic or hereditary factors. […] Nevertheless, having regular health check-ups can help in early detection of this disease, allowing prompt treatment. The sooner bone cancer is detected, the greater the chance of cure. Regular check-ups are also important for people at high risk of bone cancer or other types of cancer. […] Although there are no definitive preventive measures, a healthy lifestyle can help lower the risk: Stay active by exercising regularly and avoiding smoking and excessive alcohol consumption. Adopt a healthy diet by increasing consumption of fruit, vegetables, whole grains, fish and low-fat dairy products, and avoiding processed foods high in saturated fat. Maintain an ideal body weight through a combination of a healthy diet and physical activity, because obesity can increase the risk of cancer. If exposed to radiation in work or daily activities, be sure to use appropriate protection. Be aware of personal risk factors such as a family history of cancer or certain genetic conditions, and take appropriate preventative steps. Ensure adequate vitamin D intake for bone health. Avoid contact with dangerous chemicals or heavy metals that can increase the risk of bone cancer. Avoid activities that have a risk of causing bone injury. If injury occurs, seek appropriate medical treatment immediately.
  • #24 Osteosarcoma – What You Need to Know
    https://www.drugs.com/cg/osteosarcoma.html
    Do not smoke. Smoking increases your risk for new or returning cancer. Smoking can also delay healing after treatment. Ask your healthcare provider for information if you currently smoke and need help quitting. […] Limit or do not drink alcohol as directed. Limit alcohol to 2 drinks per day if you are a man. Limit alcohol to 1 drink per day if you are a woman. A drink of alcohol is 12 ounces of beer, 5 ounces of wine, or 1½ ounces of liquor. […] Eat a variety of healthy foods. Healthy foods include fruits, vegetables, whole-grain breads, low-fat dairy products, beans, lean meats, and fish. Ask if you need to be on a special diet. […] Drink liquids as directed. You may need to drink more liquid during cancer treatment. Ask your healthcare provider how much liquid to drink each day and which liquids are best for you.
  • #25 Osteosarcoma – What You Need to Know
    https://www.drugs.com/cg/osteosarcoma.html
    Do not smoke. Smoking increases your risk for new or returning cancer. Smoking can also delay healing after treatment. Ask your healthcare provider for information if you currently smoke and need help quitting. […] Limit or do not drink alcohol as directed. Limit alcohol to 2 drinks per day if you are a man. Limit alcohol to 1 drink per day if you are a woman. A drink of alcohol is 12 ounces of beer, 5 ounces of wine, or 1½ ounces of liquor. […] Eat a variety of healthy foods. Healthy foods include fruits, vegetables, whole-grain breads, low-fat dairy products, beans, lean meats, and fish. Ask if you need to be on a special diet. […] Drink liquids as directed. You may need to drink more liquid during cancer treatment. Ask your healthcare provider how much liquid to drink each day and which liquids are best for you.
  • #26 Bone Cancer Symptoms and How to Prevent It – EMC Healthcare – SAME
    https://www.emc.id/en/care-plus/bone-cancer-full-review-of-symptoms-and-early-prevention
    Unfortunately, there are no concrete steps that can be taken to prevent bone cancer because this disease is related to certain bone abnormalities, age, and genetic or hereditary factors. […] Nevertheless, having regular health check-ups can help in early detection of this disease, allowing prompt treatment. The sooner bone cancer is detected, the greater the chance of cure. Regular check-ups are also important for people at high risk of bone cancer or other types of cancer. […] Although there are no definitive preventive measures, a healthy lifestyle can help lower the risk: Stay active by exercising regularly and avoiding smoking and excessive alcohol consumption. Adopt a healthy diet by increasing consumption of fruit, vegetables, whole grains, fish and low-fat dairy products, and avoiding processed foods high in saturated fat. Maintain an ideal body weight through a combination of a healthy diet and physical activity, because obesity can increase the risk of cancer. If exposed to radiation in work or daily activities, be sure to use appropriate protection. Be aware of personal risk factors such as a family history of cancer or certain genetic conditions, and take appropriate preventative steps. Ensure adequate vitamin D intake for bone health. Avoid contact with dangerous chemicals or heavy metals that can increase the risk of bone cancer. Avoid activities that have a risk of causing bone injury. If injury occurs, seek appropriate medical treatment immediately.
  • #27 Bone Cancer Symptoms and How to Prevent It – EMC Healthcare – SAME
    https://www.emc.id/en/care-plus/bone-cancer-full-review-of-symptoms-and-early-prevention
    Unfortunately, there are no concrete steps that can be taken to prevent bone cancer because this disease is related to certain bone abnormalities, age, and genetic or hereditary factors. […] Nevertheless, having regular health check-ups can help in early detection of this disease, allowing prompt treatment. The sooner bone cancer is detected, the greater the chance of cure. Regular check-ups are also important for people at high risk of bone cancer or other types of cancer. […] Although there are no definitive preventive measures, a healthy lifestyle can help lower the risk: Stay active by exercising regularly and avoiding smoking and excessive alcohol consumption. Adopt a healthy diet by increasing consumption of fruit, vegetables, whole grains, fish and low-fat dairy products, and avoiding processed foods high in saturated fat. Maintain an ideal body weight through a combination of a healthy diet and physical activity, because obesity can increase the risk of cancer. If exposed to radiation in work or daily activities, be sure to use appropriate protection. Be aware of personal risk factors such as a family history of cancer or certain genetic conditions, and take appropriate preventative steps. Ensure adequate vitamin D intake for bone health. Avoid contact with dangerous chemicals or heavy metals that can increase the risk of bone cancer. Avoid activities that have a risk of causing bone injury. If injury occurs, seek appropriate medical treatment immediately.
  • #28 OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma
    https://www.businesswire.com/news/home/20250115320117/en/OS-Therapies-Announces-Phase-2b-Clinical-Trial-of-OST-HER2-Achieves-Primary-Endpoint-with-Statistical-Significance-in-the-Prevention-of-Recurrent-Fully-Resected-Lung-Metastatic-Osteosarcoma
    OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma […] The data demonstrate statistically significant results in the primary endpoint of the study, 12-month event free survival (‘EFS’), where an event is defined as the recurrence of metastatic osteosarcoma, in OST-HER2-treated patients when compared with the leading published historical comparable control group. […] The strong safety profile shown in this study also supports the use of OST-HER2 in this incredibly difficult-to-treat population that has no currently approved therapies. […] The achievement of the primary endpoint in the OST-HER2 phase 2b is a tremendous success that opens the possibility, for the first time, of meaningful therapy for patients suffering from osteosarcoma with lung metastases after resection.
  • #29 OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma
    https://www.businesswire.com/news/home/20250115320117/en/OS-Therapies-Announces-Phase-2b-Clinical-Trial-of-OST-HER2-Achieves-Primary-Endpoint-with-Statistical-Significance-in-the-Prevention-of-Recurrent-Fully-Resected-Lung-Metastatic-Osteosarcoma
    OST-HER2 is an innovative immunotherapy using a HER2 bioengineered form of the bacteria Listeria monocytogenes (Lm) to trigger a strong immune response against cancer cells expressing HER2. This off-the-shelf immunotherapy treatment is designed to prevent metastasis, delay recurrence, kill primary tumors expressing HER2 alone and potentially in combination with existing approved therapies, and increase overall survival. […] The US FDA granted OST-HER2 rare pediatric disease designation for osteosarcoma in 2021. […] The Company believes the market opportunity for OST-HER2 in the prevention of lung metastases is over $500 million. […] OS Therapies remains eligible to receive the PRV upon approval of OST-HER2 in recurrent, resected metastatic osteosarcoma. […] OS Therapies (NYSE-A: OSTX) (the “Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that the US Food & Drug Administration (“FDA”) granted the Company’s meeting request to gain alignment on the surrogate endpoint to support Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma.
  • #30 Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma – PubMed
    https://pubmed.ncbi.nlm.nih.gov/32354335/
    Surgery-accelerated metastasis is mediated in part through tumor supportive alterations in macrophage phenotype. […] Targeted pharmacologic therapies that prevent pro-tumor changes in macrophage phenotype could be utilized perioperatively to mitigate surgery-accelerated metastasis and improve the therapeutic benefits of surgery.
  • #31 Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma | Journal of Translational Medicine | Full Text
    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02348-2
    Surgery-accelerated metastasis is mediated in part through tumor supportive alterations in macrophage phenotype. […] Targeted pharmacologic therapies that prevent pro-tumor changes in macrophage phenotype could be utilized perioperatively to mitigate surgery-accelerated metastasis and improve the therapeutic benefits of surgery. […] Treatment with gefitinib prevented tumor-supportive alterations in macrophage phenotype and resulted in reduced metastasis. […] Peri-operative treatment with gefitinib resulted in reversal of the pro-tumor macrophage phenotype to a more anti-tumor state, which was associated with a significant reduction in metastases after surgery. […] Thus, gefitinib clearly has therapeutic value as a pharmacological adjunct to surgery in this model of osteosarcoma.
  • #32 Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7193344/
    Surgery-accelerated metastasis is mediated in part through tumor supportive alterations in macrophage phenotype. […] Targeted pharmacologic therapies that prevent pro-tumor changes in macrophage phenotype could be utilized perioperatively to mitigate surgery-accelerated metastasis and improve the therapeutic benefits of surgery. […] Peri-operative treatment with gefitinib resulted in reversal of the pro-tumor macrophage phenotype to a more anti-tumor state, which was associated with a significant reduction in metastases after surgery. […] This study provides novel insights into the mechanisms of surgery-accelerated metastasis in OS. […] Understanding these mechanisms will allow for the development of novel treatment approaches that will serve to further enhance the benefits of surgery. […] This study identifies gefitinib, an already FDA-approved medication, as a potential surgical adjunct to mitigate the unwanted consequences of surgery, thereby enhancing its benefits.
  • #33 Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925 | British Journal of Cancer
    https://www.nature.com/articles/bjc2014254
    The major limitation to the success of chemotherapy in osteosarcoma is the development of multidrug resistance (MDR). […] Preventing the emergence of MDR during chemotherapy treatment has been a high priority of clinical and investigational oncology, but it remains an elusive goal. […] Therefore, this study aims to evaluate the effects of NSC23925 on prevention of the development of MDR in osteosarcoma. […] Our findings suggest that NSC23925 may prevent the development of MDR by specifically preventing the overexpression of Pgp. […] Given the significant incidence of MDR in osteosarcoma and the lack of effective agents for prevention of MDR, NSC23925 and derivatives hold the potential to improve the outcome of cancer patients with poor prognosis due to drug resistance. […] However, preventing the development of MDR during the course of chemotherapy and exploring the underlying molecular machinery rather than reversing MDR once it has arisen may fundamentally aid in the design of strategies for overcoming MDR in cancer.
  • #34 Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925 | British Journal of Cancer
    https://www.nature.com/articles/bjc2014254
    A number of drugs, such as verapamil, cyclosporin A (CsA), VX710, XR9576, P85 (Pluronic 85) and LGD1069 (bexarotene) have been tested as the preventers that avert the development of MDR. […] Therefore, development of more potent and selective MDR preventers is needed. […] The NSC23925 is a small molecular compound that was identified as an effective and selective inhibitor of Pgp in previous studies. […] Importantly, the combination of paclitaxel and NSC23925 produced a significant inhibitory effect on the growth of xenograft ovarian cancer MDR tumour models as compared with animals treated with paclitaxel alone. […] Therefore, in this study, we evaluated the effects of NSC23925 on the prevention of the development of MDR in the osteosarcoma cell lines U-2OS and Saos. […] NSC23925 has the ability to prevent the development of MDR in human osteosarcoma U-2OS and Saos cells.
  • #35 Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925 | British Journal of Cancer
    https://www.nature.com/articles/bjc2014254
    Our findings indicate that NSC23925 can prevent the emergence of MDR in osteosarcoma by specifically preventing the expression of Pgp during chemotherapeutic drug treatment. […] NSC23925 prevents the increased expression of Pgp and therefore prevents increased efflux and/or decreased influx of drugs during chemotherapy treatment. […] These findings provide an indication of the mechanism by which NSC23925 prevents the emergence of MDR in osteosarcoma. […] The inclusion of drugs or agents that can prevent the development of MDR may enable patients who initially responded to therapy to continue responding without the development of MDR, and therefore provide significant clinical benefits. […] Preventing the overexpression of Pgp has been identified as an efficient approach to inhibit the development of MDR during chemotherapeutic drug treatment. […] In summary, our findings indicate that NSC23925 can prevent the development of MDR in osteosarcoma by specifically preventing the overexpression of Pgp during chemotherapeutic drug treatment.
  • #36 Europium-doped hybrid nano-complexes: a potential strategy for metastasis prevention in osteosarcoma – Materials Advances (RSC Publishing)
    https://pubs.rsc.org/en/content/articlelanding/2024/ma/d3ma00939d
    Metastasis is a major issue in cancer therapy, resulting in poor prognosis and death. However, there is currently no widely established prophylactic strategy for early metastasis in the clinical setting. […] Taken together, our results provide evidences that the Eu:SPIO@BSA nano-complex, with precise delivery, higher hemocompatibility and low liver toxicity, is a potential candidate for improving the therapeutic efficacy of metastasis prevention in osteosarcoma.
  • #37 Pediatric Osteosarcoma Medication: Antineoplastic agents, Antiemetic agents, Colony-stimulating factors, Antidotes
    https://emedicine.medscape.com/article/988516-medication
    Trimethoprim-sulfamethoxazole: At some treatment centers, clinicians routinely prescribe prophylaxis against pneumocystic pneumonia; others do not. […] Clotrimazole: Prophylactic therapy for thrush may be discontinued when chemotherapy has been completed. […] Chlorhexidine mouth rinse: Prophylaxis against gingivitis and other mouth infections may be discontinued when chemotherapy is completed.
  • #38 Tackling new strategies for canine bone cancer at MCC | Masonic Cancer Center
    https://cancer.umn.edu/news/tackling-new-strategies-canine-bone-cancer-mcc
    Osteosarcoma, the most common form of bone cancer in dogs, is a tumor that usually affects the limbs of middle-aged to older, large breed dogs and carries a dire prognosis. […] Our projects are addressing the impact of this disease by developing strategies for prevention with the intent of reducing overall incidence and by improving our understanding of how we can use the immune system to improve treatment outcomes. […] The interplay between cancer research and care for animals and cancer research and care for humans is critical to uncovering new knowledge and strategies for writing cancer’s last chapter.
  • #39 AKC Canine Health Foundation | New Researchers Tackle New Strategies for Canine Bone Cancer
    https://www.akcchf.org/educational-resources/library/articles/new-researchers-tackle-new.html
    We need new strategies to treat and even prevent bone cancer in dogs! […] One CHF-funded study is examining why dogs and children with immune cells inside their bone tumors survive longer than those whose immune cells remain outside of the tumors. […] Understanding the immune landscape that leads to improved clinical responses is a deliberate step toward a brighter future for dogs facing this devastating disease. […] Our projects are addressing the impact of this disease by developing strategies for prevention, with the intent of reducing its overall incidence, and by improving our understanding for how we can use the immune system to improve treatment outcomes.
  • #40 AKC Canine Health Foundation | Canine Osteosarcoma Early Detection: Preliminary Results from the COED Study
    https://www.akcchf.org/educational-resources/Webinars/canine-osteosarcoma-early.html
    Primary bone cancers (called osteosarcomas) affect more than 8,000 dogs, and possibly as many as 50,000 dogs per year in the United States. […] Thus, better strategies to manage this cancer are needed. To meet this need, investigators are developing tests that allow the detection of osteosarcoma at or near its origin. Early detection, in turn, will enable the deployment of strategic prevention in dogs at high risk. […] investigators will review their progress in developing a blood test for early detection of osteosarcoma as the initial step in their long-term strategy of early detection and targeted prevention for this deadly cancer.
  • #41 Osteosarcoma in Dogs – DogCancer.com
    https://www.dogcancer.com/articles/types-of-dog-cancer/osteosarcoma-in-dogs/
    There is no absolute way to prevent osteosarcoma, although there may be ways to lower the risk. In high-risk breeds, consider delaying spay or neuter surgery until at least one year of age and allow females to go through at least one heat cycle. Early evidence suggests this may reduce risk, although it is not a guaranteed prevention strategy.
  • #42 Can Osteosarcoma Be Prevented? | American Cancer Society
    https://www.cancer.org/cancer/types/osteosarcoma/causes-risks-prevention/prevention.html
    The risk of many adult cancers can be reduced with certain lifestyle changes (such as staying at a healthy weight or quitting smoking), but at this time there are no known ways to prevent osteosarcoma. […] Other than exposure to radiation (usually during radiation therapy), there are no known lifestyle-related or environmental causes of osteosarcoma, so at this time there is no known way to protect against or prevent most of these cancers.
  • #43 Osteosarcoma Risk Factors and Prevention Measures | HCG
    https://www.hcgoncology.com/types-of-cancers/osteosarcoma-prevention/
    Osteosarcoma prevention primarily involves understanding and addressing risk factors. While it may not be entirely preventable, avoiding therapeutic radiation when possible, managing pre-existing bone conditions, and staying vigilant for hereditary factors can contribute to osteosarcoma prevention. Regular medical check-ups and awareness of potential symptoms enhance early detection and intervention. […] While specific osteosarcoma prevention methods may be limited, proactive measures such as understanding risk factors and seeking timely medical attention can significantly impact outcomes. A comprehensive approach involving risk reduction and early detection is crucial for managing osteosarcoma.
  • #44 Tackling new strategies for canine bone cancer at MCC | Masonic Cancer Center
    https://cancer.umn.edu/news/tackling-new-strategies-canine-bone-cancer-mcc
    Osteosarcoma, the most common form of bone cancer in dogs, is a tumor that usually affects the limbs of middle-aged to older, large breed dogs and carries a dire prognosis. […] Our projects are addressing the impact of this disease by developing strategies for prevention with the intent of reducing overall incidence and by improving our understanding of how we can use the immune system to improve treatment outcomes. […] The interplay between cancer research and care for animals and cancer research and care for humans is critical to uncovering new knowledge and strategies for writing cancer’s last chapter.